Abstract
Symptoms of schizophrenia may reflect different pathophysiological processes in the striatum, but the links between striatal subfield connectivity, symptom dimensions, and molecular architectures remain unclear. Using connectivity profiles from 12 striatal subfields to predict negative, positive, affective, and cognitive symptoms in schizophrenia, we identified consistent connectivity features through cross-validations and validated with leave-one-site-out analysis and an independent dataset. Feature importance scores for brain parcels linked through consistent connectivity features that predicted symptoms were spatially correlated with density maps of 19 receptors/transporters from prior molecular imaging in healthy populations using partial least squares. We found that the connectivity profiles of the rostral and ventral striatal subfields significantly predicted affective and cognitive symptoms, respectively, and these predictions were generalized to the independent sample. Feature importance scores for brain parcels connected to the ventral striatum (predicting cognitive symptoms) were spatially correlated with density maps of both the vesicular acetylcholine transporter and the serotonin 1 A receptor. By contrast, importance scores for parcels linked to rostral striatal connectivity (predicting affective symptoms) were specifically associated with the spatial distribution of the serotonin 1 A receptor. Here, we show specific striatal connectivity patterns related to symptom dimensions and indicate multiple neurotransmitter systems to underlie the reward-related disturbances in schizophrenia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 13 print issues and online access
$259.00 per year
only $19.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
Data availability
Information for the main sample used in the present study have been included in the Supplementary Materials. The raw data of the main sample recruited from 7 international institutions are protected and are not publicly available due to data privacy. These data can be accessed upon reasonable request to the principal investigator of each data collection institution. Derived data supporting the findings of this study are available from the corresponding author (chen.ji@sjtu.edu.cn) upon request. The B-SNIP data that support the findings of this study are publicly available on the database of the NIMH Data Archive (NDA, https://nda.nih.gov/); a data access request must be approved to protect the confidentiality of participants. The density maps of 19 neurotransmitter receptors and transporters for the partial least square regression analysis are available at https://github.com/netneurolab/hansen_receptors. Source data are provided with this paper. MATLAB scripts to run the main analyses have been made publicly available via the Open Science Framework and can be accessed at https://osf.io/auy4n. Matlab scripts written to perform additional post-hoc analyses are available from the authors upon request. Code used to perform sparse canonical correlation analysis is available at https://github.com/cedricx/sCCA/tree/master/sCCA/code/final.
References
Jobe TH, Harrow M. Schizophrenia Course, Long-Term Outcome, Recovery, and Prognosis. Curr Dir Psychol Sci. 2010;19:220–25.
Andreasen NC, Nopoulos P, Schultz S, Miller D, Gupta S, Swayze V, et al. Positive and Negative Symptoms of Schizophrenia - Past, Present, and Future. Acta Psychiat Scand. 1994;90:51–9.
Chen J, Patil KR, Weis S, Sim K, Nickl-Jockschat T, Zhou J, et al. Neurobiological Divergence of the Positive and Negative Schizophrenia Subtypes Identified on a New Factor Structure of Psychopathology Using Non-negative Factorization: An International Machine Learning Study. Biol Psychiat. 2020;87:282–93.
Li A, Zalesky A, Yue W, Howes O, Yan H, Liu Y, et al. A neuroimaging biomarker for striatal dysfunction in schizophrenia. Nat Med. 2020;26:558–65.
Sarpal DK, Robinson DG, Lencz T, Argyelan M, Ikuta T, Karlsgodt K, et al. Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia. JAMA Psychiat. 2015;72:5–13.
Ford AA, Triplett W, Sudhyadhom A, Gullett J, McGregor K, FitzGerald DB, et al. Broca’s area and its striatal and thalamic connections: a diffusion-MRI tractography study. Front Neuroanat. 2013;7:1–12.
McCutcheon RA, Abi-Dargham A, Howes OD. Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms. Trends Neurosci. 2019;42:205–20.
Yoon JH, Minzenberg MJ, Raouf S, D’Esposito M, Carter CS. Impaired Prefrontal-Basal Ganglia Functional Connectivity and Substantia Nigra Hyperactivity in Schizophrenia. Biol Psychiat. 2013;74:122–29.
Heinz A, Murray GK, Schlagenhauf F, Sterzer P, Grace AA, Waltz JA. Towards a unifying cognitive, neurophysiological, and computational neuroscience account of schizophrenia. Schizophrenia Bull. 2019;45:1092–100.
Ehrlich S, Yendiki A, Greve DN, Manoach DS, Ho BC, White T, et al. Striatal function in relation to negative symptoms in schizophrenia. Psychol Med. 2012;42:267–82.
Fornito A, Harrison BJ, Goodby E, Dean A, Ooi C, Nathan PJ, et al. Functional Dysconnectivity of Corticostriatal Circuitry as a Risk Phenotype for Psychosis. JAMA Psychiat. 2013;70:1143–51.
Shukla DK, Chiappelli JJ, Sampath H, Kochunov P, Hare SM, Wisner K, et al. Aberrant Frontostriatal Connectivity in Negative Symptoms of Schizophrenia. Schizophrenia Bull. 2019;45:1051–59.
Sorg C, Manoliu A, Neufang S, Myers N, Peters H, Schwerthöffer D, et al. Increased Intrinsic Brain Activity in the Striatum Reflects Symptom Dimensions in Schizophrenia. Schizophrenia Bull. 2013;39:387–95.
Uno Y, Coyle JT. Glutamate hypothesis in schizophrenia. Psychiat Clin Neuros. 2019;73:204–15.
Higley MJ, Picciotto MR. Neuromodulation by acetylcholine: examples from schizophrenia and depression. Curr Opin Neurobiol. 2014;29:88–95.
Yang AC, Tsai S-J. New targets for schizophrenia treatment beyond the dopamine hypothesis. Int J Mol Sci. 2017;18:1689.
Wassef A, Baker J, Kochan LD. GABA and schizophrenia: a review of basic science and clinical studies. J Clin Psychopharmacol. 2003;23:601–40.
Chen J, Muller VI, Dukart J, Hoffstaedter F, Baker JT, Holmes AJ, et al. Intrinsic Connectivity Patterns of Task-Defined Brain Networks Allow Individual Prediction of Cognitive Symptom Dimension of Schizophrenia and Are Linked to Molecular Architecture. Biol Psychiat. 2021;89:308–19.
Huang H, Wang X, Qin X, Xu R, Xiong Y, Chen C, et al. Distinct structural deficits in treatment-resistant schizophrenia and their putative neurotransmitter basis: a source-based morphometry analysis. Neuropsychopharmacol. 2025;50:1–10.
Yao G, Pan J, Zou T, Li J, Li J, He X, et al. Structure–function coupling changes in first-episode, treatment-naïve schizophrenia correlate with cell type-specific transcriptional signature. BMC Med. 2024;22:491.
Jiang Y, Palaniyappan L, Luo C, Chang X, Zhang J, Tang Y, et al. Neuroimaging epicenters as potential sites of onset of the neuroanatomical pathology in schizophrenia. Sci Adv. 2024;10:eadk6063.
Ding C, Li A, Xie S, Tian X, Li K, Fan L, et al. Mapping brain synergy dysfunction in schizophrenia: Understanding individual differences and underlying molecular mechanisms. Adv Sci. 2024;11:2400929.
García-San-Martín N, Bethlehem RA, Segura P, Mihalik A, Seidlitz J, Sebenius I, et al. Reduced brain structural similarity is associated with maturation, neurobiological features, and clinical status in schizophrenia. Nat Commun. 2025;16:8745.
Jiang Y, Palaniyappan L, Chang X, Zhang J, Zhou E, Yu X, et al. Gray matter volume heterogeneity by stage, site of origin and pathophysiology in schizophrenia. Nature Mental Health. 2025;3:1–11.
Luo Y, Dong D, Huang H, Zhou J, Zuo X, Hu J, et al. Associating multimodal neuroimaging abnormalities with the transcriptome and neurotransmitter signatures in schizophrenia. Schizophrenia Bull. 2023;49:1554–67.
Hou C, Jiang S, Liu M, Li H, Zhang L, Duan M, et al. Spatiotemporal dynamics of functional connectivity and association with molecular architecture in schizophrenia. Cereb Cortex. 2023;33:9095–104.
Guo Z, Xiao S, Sun S, Su T, Tang X, Chen G, et al. Neural Activity Alterations and Their Association With Neurotransmitter and Genetic Profiles in Schizophrenia: Evidence From Clinical Patients and Unaffected Relatives. CNS Neurosci Therapeut. 2025;31:e70218.
Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatr. 2005;10:79–104.
Tandon R. Antipsychotics in the Treatment of Schizophrenia: An Overview. J Clin Psychiat. 2011;72:4–8.
Liu XJ, Eickhoff SB, Hoffstaedter F, Genon S, Caspers S, Reetz K, et al. Joint Multi-modal Parcellation of the Human Striatum: Functions and Clinical Relevance. Neurosci Bull. 2020;36:1123–36.
Hansen JY, Shafiei G, Markello RD, Smart K, Cox SML, Norgaard M, et al. Mapping neurotransmitter systems to the structural and functional organization of the human neocortex. Nat Neurosci. 2022;25:1569.
Cheng B, Chen J, Konigsberg A, Mayer C, Rimmele L, Patil KR, et al. Mapping the deficit dimension structure of the National Institutes of Health Stroke Scale. Ebiomedicine. 2023;87:104425.
Zimmermann S, Sakreida K, Bludau S, Camilleri JA, Hoffstaedter F, Pelzer DI, et al. Asymmetry, cytoarchitectonic morphology and genetics associated with Broca’s area in schizophrenia. Nat Ment Health. 2024;2:310–19.
Grahn JA, Parkinson JA, Owen AM. The cognitive functions of the caudate nucleus. Prog Neurobiol. 2008;86:141–55.
Morris R, Vercammen A, Lenroot R, Moore L, Langton JM, Short B, et al. Disambiguating ventral striatum fMRI-related BOLD signal during reward prediction in schizophrenia. Mol Psychiatr. 2012;17:280–89.
O’doherty JP. Reward representations and reward-related learning in the human brain: insights from neuroimaging. Curr Opin Neurobiol. 2004;14:769–76.
Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010;35:4–26.
Marchand WR, Lee JN, Suchy Y, Garn C, Chelune G, Johnson S, et al. Functional architecture of the cortico-basal ganglia circuitry during motor task execution: Correlations of strength of functional connectivity with neuropsychological task performance among female subjects. Hum Brain Mapp. 2013;34:1194–207.
Robinson JL, Laird AR, Glahn DC, Blangero J, Sanghera MK, Pessoa L, et al. The functional connectivity of the human caudate: an application of meta-analytic connectivity modeling with behavioral filtering. Neuroimage. 2012;60:117–29.
Suslow T, Kugel H, Reber H, Bauer J, Dannlowski U, Kersting A, et al. Automatic brain response to facial emotion as a function of implicitly and explicitly measured extraversion. Neuroscience. 2010;167:111–23.
Goghari VM, Sanford N, Spilka MJ, Woodward TS. Task-Related Functional Connectivity Analysis of Emotion Discrimination in a Family Study of Schizophrenia. Schizophr Bull. 2017;43:1348–62.
Seger CA. The visual corticostriatal loop through the tail of the caudate: circuitry and function. Front Syst Neurosci. 2013;7:104.
Yang GJ, Murray JD, Repovs G, Cole MW, Savic A, Glasser MF, et al. Altered global brain signal in schizophrenia. Proc Natl Acad Sci. 2014;111:7438–43.
Schaefer A, Kong R, Gordon EM, Laumann TO, Zuo XN, Holmes AJ, et al. Local-Global Parcellation of the Human Cerebral Cortex from Intrinsic Functional Connectivity MRI. Cereb Cortex. 2018;28:3095–114.
Tian Y, Margulies DS, Breakspear M, Zalesky A. Topographic organization of the human subcortex unveiled with functional connectivity gradients. Nat Neurosci. 2020;23:1421.
Xia X, Fan L, Cheng C, Eickhoff SB, Chen J, Li H, et al. Multimodal connectivity-based parcellation reveals a shell-core dichotomy of the human nucleus accumbens. Hum Brain Mapp. 2017;38:3878–98.
Kim HE, Kim J-J, Seok J-H, Park JY, Oh J. Resting-state functional connectivity and cognitive performance in aging adults with cognitive decline: A data-driven multivariate pattern analysis. Comprehensive Psychiatry. 2023;152445:1–10.
Chen JZ, Ooi LQR, Tan TWK, Zhang SS, Li JW, Asplund CL, et al. Relationship between prediction accuracy and feature importance reliability: An empirical and theoretical study. Neuroimage. 2023;274:1–13.
Chen J, Patil KR, Yeo BTT, Eickhoff SB. Leveraging Machine Learning for Gaining Neurobiological and Nosological Insights in Psychiatric Research. Biol Psychiat. 2023;93:18–28.
Nesterov Y. Subgradient methods for huge-scale optimization problems. Math Program. 2014;146:275–97.
He T, An LJ, Chen PS, Chen JZ, Feng JS, Bzdok D, et al. Meta-matching as a simple framework to translate phenotypic predictive models from big to small data. Nat Neurosci. 2022;25:795.
Haufe S, Meinecke F, Görgen K, Dähne S, Haynes JD, Blankertz B, et al. On the interpretation of weight vectors of linear models in multivariate neuroimaging. Neuroimage. 2014;87:96–110.
Wu JX, Li JW, Eickhoff SB, Scheinost D, Genon S. The challenges and prospects of brain-based prediction of behaviour. Nat Hum Behav. 2023;7:1255–64.
Xia CH, Ma Z, Ciric R, Gu S, Betzel RF, Kaczkurkin AN, et al. Linked dimensions of psychopathology and connectivity in functional brain networks. Nat Commun. 2018;9:3003.
van den Berg RA, Hoefsloot HCJ, Westerhuis JA, Smilde AK, van der Werf MJ. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics. 2006;7:1–15.
Wei Y, de Lange SC, Pijnenburg R, Scholtens LH, Ardesch DJ, Watanabe K, et al. Wiley Online Library, 2022.
Váša F, Seidlitz J, Romero-Garcia R, Whitaker KJ, Rosenthal G, Vértes PE, et al. Adolescent tuning of association cortex in human structural brain networks. Cereb Cortex. 2018;28:281–94.
Feng L, Liu Z, Li C, Li Z, Lou X, Shao L, et al. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digital Health. 2022;4:e8–e17.
Yeo BT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106:1125–65.
Mueller S, Wang DH, Pan RQ, Holt DJ, Liu HS. Abnormalities in Hemispheric Specialization of Caudate Nucleus Connectivity in Schizophrenia. Jama Psychiat. 2015;72:552–60.
Zhang B, Lin P, Wang XS, Öngür D, Ji XL, Situ WJ, et al. Altered Functional Connectivity of Striatum Based on the Integrated Connectivity Model in First-Episode Schizophrenia. Front Psychiatry. 2019;10:1–13.
Johnston PJ, Stojanov W, Devir H, Schall U. Functional MRI of facial emotion recognition deficits in schizophrenia and their electrophysiological correlates. Eur J Neurosci. 2005;22:1221–32.
Derntl B, Finkelmeyer A, Voss B, Eickhoff SB, Kellermann T, Schneider F, et al. Neural correlates of the core facets of empathy in schizophrenia. Schizophr Res. 2012;136:70–81.
Abramowitz AC, Ginger EJ, Gollan JK, Smith MJ. Empathy, depressive symptoms, and social functioning among individuals with schizophrenia. Psychiatry Res. 2014;216:325–32.
Fallon N, Roberts C, Stancak A. Shared and distinct functional networks for empathy and pain processing: a systematic review and meta-analysis of fMRI studies. Soc Cogn Affect Neurosci. 2020;15:709–23.
Ryun S, Kim M, Kim JS, Chung CK. Cortical maps of somatosensory perception in human. Neuroimage. 2023;276:1–14.
Horan WP, Jimenez AM, Lee J, Wynn JK, Eisenberger NI, Green MF. Pain empathy in schizophrenia: an fMRI study. Soc Cogn Affect Neurosci. 2016;11:783–92.
Uddin LQ. Salience processing and insular cortical function and dysfunction. Nat Rev Neurosci. 2015;16:55–61.
Roelofs K, Bramson B, Toni I. A neurocognitive theory of flexible emotion control: The role of the lateral frontal pole in emotion regulation. Ann N Y Acad Sci. 2023;1525:28–40.
Pizzagalli DA, Roberts AC. Prefrontal cortex and depression. Neuropsychopharmacol. 2022;47:225–46.
Willinger, Karipidis III D, Neuer S, Emery S, Rauch C, Haberling I, et al. Maladaptive Avoidance Learning in the Orbitofrontal Cortex in Adolescents With Major Depression. Biol Psychiat-Cogn N. 2022;7:293–301.
Liang S, Wu Y, Hanxiaoran L, Greenshaw AJ, Li T. Anhedonia in depression and schizophrenia: Brain reward and aversion circuits. Neuropsychiatr Dis Treat. 2022;18:1385.
Kondo H, Osaka N, Osaka M. Cooperation of the anterior cingulate cortex and dorsolateral prefrontal cortex for attention shifting. Neuroimage. 2004;23:670–79.
Silva A, Limongi R, MacKinley M, Palaniyappan L. Small words that matter: linguistic style and conceptual disorganization in untreated first-episode schizophrenia. Schizophrenia Bull Open. 2021;2:sgab010.
Guillem F, Rinaldi M, Pampoulova T, Stip E. The complex relationships between executive functions and positive symptoms in schizophrenia. Psychol Med. 2008;38:853–60.
Clark LK, Warman D, Lysaker PH. The relationships between schizophrenia symptom dimensions and executive functioning components. Schizophr Res. 2010;124:169–75.
Dabiri M, Dehghani Firouzabadi F, Yang K, Barker PB, Lee RR, Yousem DM. Neuroimaging in schizophrenia: A review article. Front Neurosci. 2022;16:1042814.
Di Martino A, Scheres A, Margulies DS, Kelly AM, Uddin LQ, Shehzad Z, et al. Functional connectivity of human striatum: a resting state FMRI study. Cereb Cortex. 2008;18:2735–47.
Haber SN, Fudge JL, McFarland NR. Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci. 2000;20:2369–82.
Catani M, Dell’Acqua F, De Schotten MT. A revised limbic system model for memory, emotion and behaviour. Neurosci Biobehav Rev. 2013;37:1724–37.
Mucci A, Dima D, Soricelli A, Volpe U, Bucci P, Frangou S, et al. Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? A functional magnetic resonance imaging study during reward anticipation and feedback. Psychol Med. 2015;45:1765–78.
Von Der Heide RJ, Skipper LM, Klobusicky E, Olson IR. Dissecting the uncinate fasciculus: disorders, controversies and a hypothesis. Brain. 2013;136:1692–707.
Wolff M, Vann SD. The Cognitive Thalamus as a Gateway to Mental Representations. J Neurosci. 2019;39:3–14.
Andreasen NC, OLeary DS, Cizadlo T, Arndt S, Rezai K, Ponto LLB, et al. Schizophrenia and cognitive dysmetria: A positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci USA. 1996;93:9985–90.
Griffin JD, Fletcher PC. Predictive Processing, Source Monitoring, and Psychosis. Annu Rev Clin Psycho. 2017;13:265–89.
Andreasen NC, Paradiso S, O’Leary DS. Cognitive dysmetria” as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophrenia Bull. 1998;24:203–18.
Forsyth JK, Bolbecker AR, Mehta CS, Klaunig MJ, Steinmetz JE, O’Donnell BF, et al. Cerebellar-dependent eyeblink conditioning deficits in schizophrenia spectrum disorders. Schizophrenia Bull. 2012;38:751–59.
Wang Z, Xue K, Kang Y, Liu Z, Cheng J, Zhang Y, et al. Altered intrinsic neural activity and its molecular analyses in first-episode schizophrenia with auditory verbal hallucinations. Front Neurosci. 2024;18:1478963.
Amenta F, Tayebati SK. Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction. Curr Med Chem. 2008;15:488–98.
Xu M-y, Wong AH. GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia. Acta Pharmacol Sin. 2018;39:733–53.
Lawn T, Giacomel A, Martins D, Veronese M, Howard M, Turkheimer FE, et al. Normative modelling of molecular-based functional neurocircuits captures clinical heterogeneity transdiagnostically in neuropsychiatric patients. bioRxiv. 2023:2023.10. 21.563428.
Wallace TL, Porter RHP. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Biochem Pharmacol. 2011;82:891–903.
Mortimer AM. Cognitive function in schizophrenia—do neuroleptics make a difference? Pharmacol Biochem Behav. 1997;56:789–95.
Shimizu S, Mizuguchi Y, Ohno Y. Improving the Treatment of Schizophrenia: Role of 5-HT Receptors in Modulating Cognitive and Extrapyramidal Motor Functions. CNS Neurol Disord-Dr. 2013;12:861–69.
Passchier J, van Waarde A. Visualisation of serotonin-1A (5-HT 1A) receptors in the central nervous system. Eur J Nucl Med. 2001;28:113–29.
Akimova E, Lanzenberger R, Kasper S. The serotonin-1A receptor in anxiety disorders. Biol Psychiat. 2009;66:627–35.
Savitz J, Lucki I, Drevets WC. 5-HT1A receptor function in major depressive disorder. Prog Neurobiol. 2009;88:17–31.
Gray JA, Roth BL. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophr Bull. 2007;33:1100–19.
Singh S, Khanna D, Kalra S. Role of neurochemicals in schizophrenia. Curr Psychopharmacol. 2020;9:144–61.
Greene AS, Gao SY, Scheinost D, Constable RT. Task-induced brain state manipulation improves prediction of individual traits. Nat Commun. 2018;9.
Sarpal DK, Argyelan M, Robinson DG, Szeszko PR, Karlsgodt KH, John M, et al. Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment. Am J Psychiat. 2016;173:69–77.
Paul T, See JW, Vijayakumar V, Njideaka-Kevin T, Loh H, Lee VJQ, et al. Neurostructural changes in schizophrenia and treatment-resistance: a narrative review. Psychoradiology. 2024;4.
Gell M, Eickhoff SB, Omidvarnia A, Küppers V, Patil KR, Satterthwaite TD, et al. How measurement noise limits the accuracy of brain-behaviour predictions. Nat Commun. 2024;15:10678.
Funding
This work was supported by the National Natural Science Foundation of China (No. 82201658 & No. 82371506 [to J.C.]), the Shanghai Rising-Star Program (24QA2704700 [to J.C.]), the STI2030-Major Projects (No. 2022ZD0214000 [to J.C.]), and the German Center for Mental Health (to T.N.-J.).
Author information
Authors and Affiliations
Contributions
J.C. and Y.L. conceptualized the study and designed the research. J.C., Y.L., and S.B.E interpreted the results and provided critical revisions of the manuscript. Z.H., W.H., W.W., and Z.C. analyzed the data and made figures; Z.H. and J.C. wrote the original draft. X.L. provided striatal parcellation atlases. T.N.J., B.D., L.K., R.J., O.G., A.A., I.E.S., provided the data. J.D., W.L., J.T.B., A.J.H., F.H., K.R.P., and Y.L. provided guidance on result interpretation and edited the paper. All authors approved the final version of the manuscript for submission.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
He, Z., He, W., Chen, Z. et al. Intrinsic connectivity patterns of striatal subfields predict individual dimensions of psychopathology and are associated with cholinergic and serotonergic neurotransmission in schizophrenia. Neuropsychopharmacol. 51, 956–967 (2026). https://doi.org/10.1038/s41386-026-02354-w
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41386-026-02354-w


